Invesco’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Invesco’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-66,396	Closed	-$1.32M	–	4109
2022 Q3	$1.32M	Sell	66,396 -1,872	-3%	-$24.7K	﹤0.01%	2816
2022 Q2	$470K	Buy	68,268 +11,220	+20%	+$78.7K	﹤0.01%	3355
2022 Q1	$531K	Buy	57,048 +45,115	+378%	+$480K	﹤0.01%	3360
2021 Q4	$170K	Sell	11,933 -1,957	-14%	-$33.9K	﹤0.01%	3817
2021 Q3	$323K	Buy	13,890 +1,503	+12%	+$35.5K	﹤0.01%	3627
2021 Q2	$308K	Buy	+12,387	New	+$333K	﹤0.01%	3621

Invesco's FMTX Position: Q4 2022 in Review

Invesco sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 66,396 shares — an estimated $1.32M sold.

Invesco first reported a position in FMTX in Q2 2021 and held it in 6 quarters. The position peaked at $1.32M in Q3 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

Invesco reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Invesco sold 66,396 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $1.32M.
Invesco first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q2 2021 and held it in 6 quarters.
Invesco's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $1.32M in Q3 2022.
0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Invesco's 13F filing for Q4 2022, filed 13 Feb 2023.